[Beta-carotin treatment of erythropoietic protoporphyria].
D000284:Administration, Oral; D000328:Adult; D002338:Carotenoids / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D004920:Erythropoiesis; D005260:Female; D006801:Humans; D008027:Light / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000188:drug therapy*; D011166:Porphyrins / Q000097:blood; D012621:Seasons; D013472:Sunlight; D013997:Time Factors
D011166:Porphyrins; D002338:Carotenoids
Zur Beta-Karotin-Behandlung der erythropoetischen Protoporphyrie